SNIP1_HUMAN - dbPTM
SNIP1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID SNIP1_HUMAN
UniProt AC Q8TAD8
Protein Name Smad nuclear-interacting protein 1
Gene Name SNIP1
Organism Homo sapiens (Human).
Sequence Length 396
Subcellular Localization Nucleus .
Protein Description Down-regulates NF-kappa-B signaling by competing with RELA for CREBBP/EP300 binding. Involved in the microRNA (miRNA) biogenesis. May be involved in cyclin-D1/CCND1 mRNA stability through the SNARP complex which associates with both the 3'end of the CCND1 gene and its mRNA..
Protein Sequence MKAVKSERERGSRRRHRDGDVVLPAGVVVKQERLSPEVAPPAHRRPDHSGGSPSPPTSEPARSGHRGNRARGVSRSPPKKKNKASGRRSKSPRSKRNRSPHHSTVKVKQEREDHPRRGREDRQHREPSEQEHRRARNSDRDRHRGHSHQRRTSNERPGSGQGQGRDRDTQNLQAQEEEREFYNARRREHRQRNDVGGGGSESQELVPRPGGNNKEKEVPAKEKPSFELSGALLEDTNTFRGVVIKYSEPPEARIPKKRWRLYPFKNDEVLPVMYIHRQSAYLLGRHRRIADIPIDHPSCSKQHAVFQYRLVEYTRADGTVGRRVKPYIIDLGSGNGTFLNNKRIEPQRYYELKEKDVLKFGFSSREYVLLHESSDTSEIDRKDDEDEEEEEEVSDS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MKAVKSERE
------CCCCCCCHH
62.9825953088
5Sumoylation---MKAVKSERERGS
---CCCCCCCHHHCC
52.00-
5Acetylation---MKAVKSERERGS
---CCCCCCCHHHCC
52.0025953088
6Phosphorylation--MKAVKSERERGSR
--CCCCCCCHHHCCC
34.9726437602
12PhosphorylationKSERERGSRRRHRDG
CCCHHHCCCCCCCCC
28.92-
30SumoylationLPAGVVVKQERLSPE
ECCEEEEEECCCCCC
34.53-
30SumoylationLPAGVVVKQERLSPE
ECCEEEEEECCCCCC
34.5325114211
30AcetylationLPAGVVVKQERLSPE
ECCEEEEEECCCCCC
34.5325953088
35PhosphorylationVVKQERLSPEVAPPA
EEEECCCCCCCCCCC
25.8229255136
49PhosphorylationAHRRPDHSGGSPSPP
CCCCCCCCCCCCCCC
52.8329255136
52PhosphorylationRPDHSGGSPSPPTSE
CCCCCCCCCCCCCCC
26.2329255136
54PhosphorylationDHSGGSPSPPTSEPA
CCCCCCCCCCCCCCC
45.2529255136
57PhosphorylationGGSPSPPTSEPARSG
CCCCCCCCCCCCCCC
49.4530266825
58PhosphorylationGSPSPPTSEPARSGH
CCCCCCCCCCCCCCC
47.5629255136
63PhosphorylationPTSEPARSGHRGNRA
CCCCCCCCCCCCCCC
40.8528111955
74PhosphorylationGNRARGVSRSPPKKK
CCCCCCCCCCCCCCC
29.8423401153
76PhosphorylationRARGVSRSPPKKKNK
CCCCCCCCCCCCCCC
37.7423401153
79AcetylationGVSRSPPKKKNKASG
CCCCCCCCCCCCCCC
78.6812432625
80AcetylationVSRSPPKKKNKASGR
CCCCCCCCCCCCCCC
68.3112432635
89PhosphorylationNKASGRRSKSPRSKR
CCCCCCCCCCCCHHC
35.8017081983
91PhosphorylationASGRRSKSPRSKRNR
CCCCCCCCCCHHCCC
27.1317081983
99PhosphorylationPRSKRNRSPHHSTVK
CCHHCCCCCCCCCCC
31.9422167270
103PhosphorylationRNRSPHHSTVKVKQE
CCCCCCCCCCCCCHH
31.6820068231
104PhosphorylationNRSPHHSTVKVKQER
CCCCCCCCCCCCHHH
21.7120068231
108SumoylationHHSTVKVKQEREDHP
CCCCCCCCHHHCCCC
40.5028112733
108SumoylationHHSTVKVKQEREDHP
CCCCCCCCHHHCCCC
40.50-
128PhosphorylationDRQHREPSEQEHRRA
HHCCCCCCHHHHHHH
47.3521955146
147PhosphorylationRDRHRGHSHQRRTSN
HHHHHCCCCCCCCCC
24.9226329039
152PhosphorylationGHSHQRRTSNERPGS
CCCCCCCCCCCCCCC
37.7922167270
153PhosphorylationHSHQRRTSNERPGSG
CCCCCCCCCCCCCCC
34.5822167270
159PhosphorylationTSNERPGSGQGQGRD
CCCCCCCCCCCCCCC
30.5321955146
169PhosphorylationGQGRDRDTQNLQAQE
CCCCCCHHHHHHHHH
21.9117525332
200PhosphorylationNDVGGGGSESQELVP
CCCCCCCCCCCCCCC
37.0323401153
202PhosphorylationVGGGGSESQELVPRP
CCCCCCCCCCCCCCC
30.5617525332
223AcetylationKEVPAKEKPSFELSG
CCCCCCCCCCEEECC
45.3025953088
223UbiquitinationKEVPAKEKPSFELSG
CCCCCCCCCCEEECC
45.30-
223SumoylationKEVPAKEKPSFELSG
CCCCCCCCCCEEECC
45.3028112733
225PhosphorylationVPAKEKPSFELSGAL
CCCCCCCCEEECCEE
42.2828450419
229PhosphorylationEKPSFELSGALLEDT
CCCCEEECCEEEECC
18.1528450419
236PhosphorylationSGALLEDTNTFRGVV
CCEEEECCCCEEEEE
27.1220068231
238PhosphorylationALLEDTNTFRGVVIK
EEEECCCCEEEEEEE
19.4629759185
246PhosphorylationFRGVVIKYSEPPEAR
EEEEEEECCCCCCCC
13.7229759185
247PhosphorylationRGVVIKYSEPPEARI
EEEEEECCCCCCCCC
38.3329759185
301UbiquitinationIDHPSCSKQHAVFQY
CCCCCHHCCCEEEEE
50.89-
301AcetylationIDHPSCSKQHAVFQY
CCCCCHHCCCEEEEE
50.8925953088
308PhosphorylationKQHAVFQYRLVEYTR
CCCEEEEEEEEEEEC
8.41-
313PhosphorylationFQYRLVEYTRADGTV
EEEEEEEEECCCCCC
8.27-
314PhosphorylationQYRLVEYTRADGTVG
EEEEEEEECCCCCCC
13.08-
325AcetylationGTVGRRVKPYIIDLG
CCCCCEECCEEEEEC
30.2326051181
325UbiquitinationGTVGRRVKPYIIDLG
CCCCCEECCEEEEEC
30.23-
342UbiquitinationNGTFLNNKRIEPQRY
CCCCCCCCCCCCCEE
54.39-
349PhosphorylationKRIEPQRYYELKEKD
CCCCCCEEEECCHHC
8.9527251275
350PhosphorylationRIEPQRYYELKEKDV
CCCCCEEEECCHHCC
19.5827251275
353UbiquitinationPQRYYELKEKDVLKF
CCEEEECCHHCCEEE
51.26-
367PhosphorylationFGFSSREYVLLHESS
ECCCCCCEEEEECCC
8.6920873877
373PhosphorylationEYVLLHESSDTSEID
CEEEEECCCCCCCCC
23.8330108239
374PhosphorylationYVLLHESSDTSEIDR
EEEEECCCCCCCCCC
41.7530108239
376PhosphorylationLLHESSDTSEIDRKD
EEECCCCCCCCCCCC
30.1530108239
377PhosphorylationLHESSDTSEIDRKDD
EECCCCCCCCCCCCC
37.2330108239
394PhosphorylationEEEEEEVSDS-----
HHHHHHHCCC-----
35.1030266825
396PhosphorylationEEEEVSDS-------
HHHHHCCC-------
34.3230266825

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of SNIP1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of SNIP1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of SNIP1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SMAD4_HUMANSMAD4physical
10887155
EP300_HUMANEP300physical
10887155
CBP_HUMANCREBBPphysical
10887155
TF65_HUMANRELAphysical
11567019
ATR_HUMANATRphysical
17260016
MYC_HUMANMYCphysical
17157259
MAX_HUMANMAXphysical
17157259
PR40A_HUMANPRPF40Aphysical
22365833
SF3B1_HUMANSF3B1physical
22365833
CHERP_HUMANCHERPphysical
22365833
SRRM2_HUMANSRRM2physical
22365833
PRPF3_HUMANPRPF3physical
22365833
SNW1_HUMANSNW1physical
22365833
MFAP1_HUMANMFAP1physical
22365833
RED_HUMANIKphysical
22365833
NCBP3_HUMANC17orf85physical
22365833
TTC14_HUMANTTC14physical
22365833
ZCH10_HUMANZCCHC10physical
22365833
SRPK2_HUMANSRPK2physical
22365833
BCLF1_HUMANBCLAF1physical
26186194
TR150_HUMANTHRAP3physical
26186194
ACINU_HUMANACIN1physical
26186194
NCBP3_HUMANC17orf85physical
26186194
SRRM2_HUMANSRRM2physical
26186194
ZC3HE_HUMANZC3H14physical
26186194
PININ_HUMANPNNphysical
26186194
GPTC8_HUMANGPATCH8physical
26186194
NCBP1_HUMANNCBP1physical
26186194
CRNL1_HUMANCRNKL1physical
26186194
RBM22_HUMANRBM22physical
26186194
AQR_HUMANAQRphysical
26186194
GPAM1_HUMANGPALPP1physical
26186194
PPIG_HUMANPPIGphysical
26186194
SRSF9_HUMANSRSF9physical
26186194
SRSF1_HUMANSRSF1physical
26186194
RNPS1_HUMANRNPS1physical
26186194
CLASR_HUMANCLASRPphysical
26186194
SNW1_HUMANSNW1physical
26186194
LARP1_HUMANLARP1physical
26186194
CCDC9_HUMANCCDC9physical
26186194
CCD12_HUMANCCDC12physical
26186194
SRRT_HUMANSRRTphysical
26186194
PRP17_HUMANCDC40physical
26186194
MGN_HUMANMAGOHphysical
26186194
ISY1_HUMANISY1physical
26186194
IF4A3_HUMANEIF4A3physical
26186194
CLK3_HUMANCLK3physical
26186194
CASC3_HUMANCASC3physical
26186194
YTDC1_HUMANYTHDC1physical
26186194
NKTR_HUMANNKTRphysical
26186194
SRSF6_HUMANSRSF6physical
26186194
MKRN1_HUMANMKRN1physical
26186194
TRA2A_HUMANTRA2Aphysical
26186194
TRA2B_HUMANTRA2Bphysical
26186194
SRSF8_HUMANSRSF8physical
26186194
BUD31_HUMANBUD31physical
26186194
SPT2_HUMANSPTY2D1physical
26186194
SRS12_HUMANSRSF12physical
26186194
SRS10_HUMANSRSF10physical
26186194
DHX8_HUMANDHX8physical
26186194
CLK2_HUMANCLK2physical
26186194
NKAP_HUMANNKAPphysical
26186194
CLASR_HUMANCLASRPphysical
28514442
ACINU_HUMANACIN1physical
28514442
RNPS1_HUMANRNPS1physical
28514442
PININ_HUMANPNNphysical
28514442
CCDC9_HUMANCCDC9physical
28514442
SRSF8_HUMANSRSF8physical
28514442
NKTR_HUMANNKTRphysical
28514442
ZC3HE_HUMANZC3H14physical
28514442
CASC3_HUMANCASC3physical
28514442
CLK2_HUMANCLK2physical
28514442
PPIG_HUMANPPIGphysical
28514442
YTDC1_HUMANYTHDC1physical
28514442
SRS12_HUMANSRSF12physical
28514442
NCBP3_HUMANC17orf85physical
28514442
GPTC8_HUMANGPATCH8physical
28514442
CLK3_HUMANCLK3physical
28514442
TR150_HUMANTHRAP3physical
28514442
CRNL1_HUMANCRNKL1physical
28514442
MKRN1_HUMANMKRN1physical
28514442
GPAM1_HUMANGPALPP1physical
28514442
PRP17_HUMANCDC40physical
28514442
TRA2A_HUMANTRA2Aphysical
28514442
SRSF1_HUMANSRSF1physical
28514442
SRS10_HUMANSRSF10physical
28514442
BCLF1_HUMANBCLAF1physical
28514442
RBM22_HUMANRBM22physical
28514442
ISY1_HUMANISY1physical
28514442
AQR_HUMANAQRphysical
28514442
BUD31_HUMANBUD31physical
28514442
PAI2B_HUMANPAIP2Bphysical
28514442
NCBP1_HUMANNCBP1physical
28514442
SRRM2_HUMANSRRM2physical
28514442
CCD12_HUMANCCDC12physical
28514442
CDK3_HUMANCDK3physical
28514442
TRA2B_HUMANTRA2Bphysical
28514442
DHX8_HUMANDHX8physical
28514442
PPIE_HUMANPPIEphysical
28514442
SRSF9_HUMANSRSF9physical
28514442
SNW1_HUMANSNW1physical
28514442
IF4A3_HUMANEIF4A3physical
28514442
RALY_HUMANRALYphysical
28514442
RL5_HUMANRPL5physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
614501Psychomotor retardation, epilepsy, and craniofacial dysmorphism (PMRED)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of SNIP1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52 AND SER-54, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35; SER-49; SER-52 ANDSER-54, AND MASS SPECTROMETRY.
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment.";
Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
J. Proteome Res. 7:5167-5176(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-394, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35, AND MASSSPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35, AND MASSSPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-169 AND SER-202, ANDMASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35; SER-89; SER-91 ANDSER-153, AND MASS SPECTROMETRY.
Sumoylation
ReferencePubMed
"PDSM, a motif for phosphorylation-dependent SUMO modification.";
Hietakangas V., Anckar J., Blomster H.A., Fujimoto M., Palvimo J.J.,Nakai A., Sistonen L.;
Proc. Natl. Acad. Sci. U.S.A. 103:45-50(2006).
Cited for: SUMOYLATION AT LYS-30, AND MUTAGENESIS OF LYS-30.

TOP